Siemens Biograph 64 PET/CT System Enables Physicians to Provide Earlier, More Pre-cise Diagnoses and Treatments of Disease
Siemens Medical Solutions today showcased the industry’s most comprehensive molecular imaging portfolio at the 2006 European/World-Congress of Cardiology, held September 2-6 in Barcelona, Spain. Recognizing the call for advanced technologies, Siemens is developing solutions that expand the field of cardiology, including c.cam, e.cam, Symbia SPECT, Symbia SPECT•CT, and Biograph PET•CT systems.
Siemens’ molecular imaging solutions provide cardiologists with functional information such as wall motion, myocardial perfusion, and in some cases plaque characterization, as well as morphological information, such as the presence of coronary calcifications and detailed car-diac anatomy. New workflow enhancements to the Symbia line of hybrid imagers include automatic and integrated collimator changing options, as well as an automatic quality control option that automates all daily, weekly and monthly quality control needs of the system. Siemens Biograph 64 with the new TruePoint PET•CT technology package performs high-resolution CT angiography and myocardial perfusion and viability in a single exam. These technologies, combined with advanced visualization tools such as syngo CardioFusion, op-timize the clinical cardiac workflow and enable enhanced diagnostic capabilities.
Molecular imaging’s ability to provide anatomical and functional detail at the cellular level can greatly impact medicine because treatment and survival are dependent upon early, accurate diagnosis and monitoring. Molecular medicine is expected to help physicians detect diseases earlier, and more specifically, to forecast the effectiveness of drugs for a patient and deter-mine the best therapy on a personalized basis.
“Siemens sees the evolving field of molecular medicine as a means to move healthcare from treating illness to promoting health through efficient prevention, accurate diagnosis, persona-lized therapy, and high quality care”, explained Michael Reitermann, president, Molecular Imaging Division, Siemens Medical Solutions. “Siemens’ solutions are driving research from the bench to the bedside, where it is most needed to increase the quality of healthcare delivery, while reducing costs.” Siemens’ molecular imaging technologies, including clinical and preclinical imagers, advanced applications and biomarkers, are enabling clinicians and researchers around the world to effectively treat within and further explore these areas.
Siemens Medical Solutions is one of the world’s largest suppliers to the healthcare industry. The company is known for bringing together innovative medical technologies, healthcare information systems, man-agement consulting, and support services, to help customers achieve tangible, sustainable, clinical and finan-cial outcomes. From imaging systems for diagnosis, to therapy equipment for treatment, to patient monitors to hearing instruments and beyond, Siemens innovations contribute to the health and well-being of people across the globe, while improving operational efficiencies and optimizing workflow in hospitals, clinics, home health agencies, and doctors' offices. Employing approximately 33.000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.6 billion EUR, orders of 8.6 billion EUR and group profit of 1 billion EUR for fiscal 2005. Further information can be found under: www.siemens.com/medical